Clinical Laboratory Tests Market To Reach $213.04 Billion By 2030

Clinical Laboratory Tests Market Growth & Trends

The global clinical laboratory tests market size is estimated to reach USD 213.04 billion by 2030, registering a CAGR of 8.88% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth of the clinical laboratory tests market is attributable to the rising prevalence of target diseases. The use of clinical laboratory tests is on a rise owing to the use of tests in a wide variety of diagnostic purposes that primarily focus on patient health leading to evaluating and formulating proper diagnosis and treatment.

The global geriatric population is increasing and is considered as being the greatest risk factor for the development of conditions, such as cardiovascular diseases and kidney dysfunction. According to WHO, the population aged above 60 years is expected to be 1 in every 6 people by 2030, which accounts for an increase from 1 billion in 2020 to 1.4 billion by 2030. In addition, the number of people aged 80 and above is projected to double to over 1.5 billion by 2050, and people aged above 80 years are expected to triple and reach 426 Billion. Thus, the growing geriatric population is expected to be a high-impact rendering driver for this market over the forecast period.

The growing prevalence of target diseases, such as CVD and diabetes, is anticipated to boost the market over the forecast period. CVD is fatal and leading cause of death worldwide. Presence of high unmet medical needs pertaining to cardiovascular diseases and the subsequent rise in patient awareness are among factors expected to boost the demand for point-of-care lipid testing. According to WHO, in 2021, cardiovascular diseases have been leading cause of mortality and morbidity worldwide in the last three decades, 17.7 Billion people die every year due to cardiovascular diseases, which is 31% of all the deaths worldwide.

Furthermore, key players involved in developing and formulating clinical laboratory tests are focusing on collaborations and partnerships to develop novel tuberculosis therapeutics and to maintain their competitive position in the market. In addition, increasing adoption of laboratory automation systems is expected to boost the market over the forecast period. For instance, in January 2023[, BD launched a third-generation total laboratory automation system, which automates lab specimen processing for microbiology laboratories. Moreover, in January 2023, NovoPath LLC expanded its LIS solutions for oncology laboratories.

 Request a free sample copy or view report summary: Clinical Laboratory Tests Market Report

Clinical Laboratory Tests Market Report Highlights

• Based on type, the HbA1c testing segment held the largest market share at 12.39% in 2024, driven primarily by the rising global prevalence of diabetes and cholesterol-related conditions.

• The HGB/HCT testing type segment is projected to grow at the fastest CAGR during the forecast period.

• By end-use, the central laboratories segment held the largest share of the market in 2024, primarily due to high test volumes and widespread market penetration.

• The primary clinics end-use segment is expected to register the fastest CAGR during the forecast period.

• North America clinical laboratory tests industry held the largest share of market in 2024 and is expected to maintain its dominant position.

Clinical Laboratory Tests Market Segmentation

Grand View Research has segmented the global clinical laboratory tests market based on type, end-use, and region:

Clinical Laboratory Tests Type Outlook (Revenue, USD Million, 2018 - 2030)

• Complete Blood Count

• HGB/ HCT testing

• Basic Metabolic Panel Testing

• BUN Creatinine Testing

• Electrolytes Testing

• HbA1c Testing

• Comprehensive Metabolic Panel Testing

• Liver Panel Testing

  • Hepatitis

  • Bile Duct Obstruction

  • Liver Cirrhosis

  • Liver Cancer

  • Bone Disease

  • Autoimmune Disorders

  • Others

• Renal Panel Testing

• Lipid Panel Testing

• Cardiovascular Panel Tests

Clinical Laboratory Tests End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Central Laboratories

  • Complete Blood Count

  • HGB/ HCT testing

  • Basic Metabolic Panel Testing

  • BUN Creatinine Testing

  • Electrolytes Testing

  • HbA1c Testing

  • Comprehensive Metabolic Panel Testing

  • Liver Panel Testing

  • Renal Panel Testing

  • Lipid Panel Testing

  • Cardiovascular Panel Tests

• Primary Clinics

  • Complete Blood Count

  • HGB/ HCT testing

  • Basic Metabolic Panel Testing

  • BUN Creatinine Testing

  • Electrolytes Testing

  • HbA1c Testing

  • Comprehensive Metabolic Panel Testing

  • Liver Panel Testing

  • Renal Panel Testing

  • Lipid Panel Testing

  • Cardiovascular Panel Tests

Clinical Laboratory Tests Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

  • Rest of Latin America

• Middle East and Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players of Clinical Laboratory Tests Market

• Quest Diagnostics Incorporated.

• Abbott

• Cinven

• Laboratory Corporation of America Holdings

• ARUP Laboratories

• OPKO Health, Inc.

• UNILABS

• Clinical Reference Laboratory, Inc.

• Synnovis Group LLP

• Sonic Healthcare Limited.